BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32071117)

  • 1. The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
    Santa-Maria CA; Coughlin JW; Sharma D; Armanios M; Blackford AL; Schreyer C; Dalcin A; Carpenter A; Jerome GJ; Armstrong DK; Chaudhry M; Cohen GI; Connolly RM; Fetting J; Miller RS; Smith KL; Snyder C; Wolfe A; Wolff AC; Huang CY; Appel LJ; Stearns V
    Clin Cancer Res; 2020 Jun; 26(12):3024-3034. PubMed ID: 32071117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study.
    Sanft T; Usiskin I; Harrigan M; Cartmel B; Lu L; Li FY; Zhou Y; Chagpar A; Ferrucci LM; Pusztai L; Irwin ML
    Breast Cancer Res Treat; 2018 Nov; 172(1):105-112. PubMed ID: 30062572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise and dietary advice intervention for survivors of triple-negative breast cancer: effects on body fat, physical function, quality of life, and adipokine profile.
    Swisher AK; Abraham J; Bonner D; Gilleland D; Hobbs G; Kurian S; Yanosik MA; Vona-Davis L
    Support Care Cancer; 2015 Oct; 23(10):2995-3003. PubMed ID: 25724409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Diet and Exercise-Induced Weight Loss on Biomarkers of Inflammation in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Bruinsma TJ; Dyer AM; Rogers CJ; Schmitz KH; Sturgeon KM
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1048-1062. PubMed ID: 33737299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
    Sheng JY; Santa-Maria CA; Blackford AL; Lim D; Carpenter A; Smith KL; Cohen GI; Coughlin J; Appel LJ; Stearns V; Snyder C
    J Cancer Surviv; 2022 Jun; 16(3):542-551. PubMed ID: 34018096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
    Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
    J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Adiponectin and Leptin Levels in Breast Cancer Survivors with Overweight or Obesity.
    Lin D; Sturgeon KM; Gordon BR; Brown JC; Sears DD; Sarwer DB; Schmitz KH
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in Inflammatory Biomarkers and Adipose Tissue in
    Sturgeon KM; Foo W; Heroux M; Schmitz K
    Cancer Prev Res (Phila); 2018 Sep; 11(9):545-550. PubMed ID: 29925515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Exercise on Insulin, IGF Axis, Adipocytokines, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Kang DW; Lee J; Suh SH; Ligibel J; Courneya KS; Jeon JY
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):355-365. PubMed ID: 27742668
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest.
    Befort CA; Kimler BF; Bantis LE; Phillips TA; Fabian CJ
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1321-1328. PubMed ID: 32277008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Inflammation in Breast Cancer Survivors.
    Sturgeon KM; Brown JC; Sears DD; Sarwer DB; Schmitz KH
    Med Sci Sports Exerc; 2023 Feb; 55(2):209-215. PubMed ID: 36170550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
    Fabian CJ; Kimler BF; Donnelly JE; Sullivan DK; Klemp JR; Petroff BK; Phillips TA; Metheny T; Aversman S; Yeh HW; Zalles CM; Mills GB; Hursting SD
    Breast Cancer Res Treat; 2013 Nov; 142(1):119-32. PubMed ID: 24141897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors.
    Dittus KL; Harvey JR; Bunn JY; Kokinda ND; Wilson KM; Priest J; Pratley RE
    BMC Cancer; 2018 Mar; 18(1):351. PubMed ID: 29587682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
    Thompson HJ; Sedlacek SM; Wolfe P; Paul D; Lakoski SG; Playdon MC; McGinley JN; Matthews SB
    Nutrients; 2015 Jun; 7(7):5156-76. PubMed ID: 26132992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial.
    van Gemert WA; May AM; Schuit AJ; Oosterhof BY; Peeters PH; Monninkhof EM
    Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):799-806. PubMed ID: 26908432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a weight loss intervention among rural breast cancer survivors.
    Befort CA; Klemp JR; Austin HL; Perri MG; Schmitz KH; Sullivan DK; Fabian CJ
    Breast Cancer Res Treat; 2012 Apr; 132(2):631-9. PubMed ID: 22198470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
    Travier N; Buckland G; Vendrell JJ; Fernandez-Veledo S; Peiró I; Del Barco S; Pernas S; Zamora E; Bellet M; Margeli M; Cirauqui B; Muñoz M; Tusquets I; Arcusa A; Javierre C; Moreno F; Rodriguez A; Agudo A
    Eur J Cancer Care (Engl); 2018 Jul; 27(4):e12861. PubMed ID: 29869823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
    Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
    Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial.
    Raji Lahiji M; Zarrati M; Najafi S; Yazdani B; Cheshmazar E; Razmpoosh E; Janani L; Raji Lahiji M; Shidfar F
    Support Care Cancer; 2021 Jul; 29(7):4147-4157. PubMed ID: 33404812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Resistance Exercise on Biomarkers of Breast Cancer Prognosis: A Pooled Analysis of Three Randomized Trials.
    Winters-Stone KM; Wood LJ; Stoyles S; Dieckmann NF
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):146-153. PubMed ID: 29141853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.